Alembic

Why is Alembic Ltd falling/rising?

As of 04-Aug, Alembic Ltd's stock price is declining, currently at 88.69, with a year-to-date drop of 12.24% and a one-year return of -22.51%. This decline is attributed to operational challenges and a lack of confidence from domestic mutual funds.

As of 04-Aug, Alembic Ltd's stock price is falling, currently at 88.69, reflecting a decrease of 2.98 (-3.25%). The stock has underperformed its sector by 3.12% today and opened with a loss of 2.62%. It has also touched an intraday low of Rs 87.52, marking a decline of 4.53%. This downward trend follows two consecutive days of gains, indicating a potential trend reversal.<BR><BR>In terms of performance over various periods, Alembic Ltd has shown significant declines, with a year-to-date drop of 12.24% and a one-year return of -22.51%. This poor performance is compounded by the company's flat results reported on March 26, where the profit before tax fell by 31.97%. Additionally, the operating profit to net sales ratio is at its lowest, indicating operational challenges.<BR><BR>Despite being net-debt free and having a healthy long-term growth rate in operating profit, the stock's valuation appears expensive with a price to book value of 0.9 and a PEG ratio of 3.3. Furthermore, the lack of investment from domestic mutual funds, which hold 0% of the company, suggests a lack of confidence in the stock's current price or business prospects.<BR><BR>Overall, the combination of recent poor performance, operational challenges, and lack of institutional support contributes to the declining stock price of Alembic Ltd.

Which are the latest news on Alembic?

What does Alembic do?

Alembic Ltd is a small-cap manufacturer of bulk drugs and pharmaceuticals for human and animal healthcare. As of March 2026, it reported net sales of 60 Cr and a net profit of 67 Cr, with a market cap of INR 2,251 Cr.

Overview:<BR>Alembic Ltd is a manufacturer of bulk drugs and pharmaceuticals formulations in human and animal healthcare, operating in the Realty industry and classified as a Small Cap company.<BR><BR>History:<BR>Alembic Ltd was incorporated in an unspecified year and has been involved in the manufacture of pharmaceuticals and chemicals. The latest quarterly results reported are for March 2026, showing net sales and profit figures.<BR><BR>Financial Snapshot:<BR>Net Sales: 60 Cr (Quarterly Results - Mar 2026)<BR>Net Profit: 67 Cr (Quarterly Results - Mar 2026)<BR>Market Cap: INR 2,251 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 7.00<BR>Industry P/E: 34<BR>Dividend Yield: 2.88%<BR>Debt Equity: -0.04<BR>Return on Equity: 12.98%<BR>Price to Book: 0.91<BR><BR>Contact Details:<BR>Address: Alembic Road, Vadodara Gujarat: 390003<BR>Tel: 91-0265-2280550<BR>Email: alembic.investors@alembic.co.in<BR>Website: http://www.alembiclimited.com

How big is Alembic?

As of 10th June, Alembic Ltd has a market capitalization of 2,251.00 Cr, with recent net sales of 239.99 Cr and a net profit of 317.39 Cr. Shareholder's funds are 2,338.59 Cr and total assets amount to 2,503.00 Cr.

As of 10th June, Alembic Ltd has a market capitalization of 2,251.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Alembic reported Net Sales of 239.99 Cr and a Net Profit of 317.39 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 2,338.59 Cr and Total Assets of 2,503.00 Cr.

Who are in the management team of Alembic?

The management team of Alembic includes Chirayu R Amin (Chairman), Malika C Amin (Managing Director & CEO), and several independent directors, including C P Buch, Sameer Khera, Rati Desai, Mayank Amin, and Girish Hirode, along with Udit Amin, Abhijit Joshi, and Drigesh Mittal (Company Secretary). This team offers a diverse range of expertise in leadership and governance.

The management team of Alembic includes the following key members:<BR><BR>1. **Chirayu R Amin** - Chairman (Non-Executive)<BR>2. **Malika C Amin** - Managing Director & CEO<BR>3. **C P Buch** - Independent Director<BR>4. **Udit Amin** - Director<BR>5. **Abhijit Joshi** - Director<BR>6. **Sameer Khera** - Independent Director<BR>7. **Drigesh Mittal** - Company Secretary & Compliance Officer<BR>8. **Rati Desai** - Independent Director<BR>9. **Mayank Amin** - Independent Director<BR>10. **Girish Hirode** - Independent Director<BR><BR>This team brings a diverse range of expertise to the company, with various roles in leadership and governance.

Who are the peers of the Alembic?

Alembic's peers include EFC (I), Marathon Nextgen, Arvind SmartSp., National Standar, Ajmera Realty, Arkade, Meghna Infracon, Shriram Properti, Omaxe, and Unitech. Alembic shows excellent growth and capital structure, while peers exhibit varying management risks and returns, with Meghna Infracon having the highest 1-year return at 42.41% and National Standar the lowest at -60.34%.

Peers: The peers of Alembic are EFC (I), Marathon Nextgen, Arvind SmartSp., National Standar, Ajmera Realty, Arkade, Meghna Infracon, Shriram Properti, Omaxe, and Unitech.<BR><BR>Quality Snapshot: Excellent management risk is observed at Arvind SmartSp., while Average management risk is found at EFC (I), Marathon Nextgen, Ajmera Realty, Arkade, Meghna Infracon, and Shriram Properti, and the rest. Growth is Excellent at Alembic, Good at Arvind SmartSp. and Ajmera Realty, Average at Meghna Infracon, and Below Average at Marathon Nextgen, National Standar, Arkade, Shriram Properti, Omaxe, and Unitech. Capital Structure is Excellent at Alembic, Good at National Standar, Average at Arvind SmartSp., Ajmera Realty, and the rest, and Below Average at EFC (I), Marathon Nextgen, Shriram Properti, Omaxe, and Unitech.<BR><BR>Return Snapshot: Meghna Infracon has the highest 1-year return at 42.41%, while National Standar has the lowest at -60.34%. Alembic's 1-year return of -27.08% is better than National Standar's but worse than Meghna Infracon's. Additionally, EFC (I), Marathon Nextgen, National Standar, Ajmera Realty, Arkade, Shriram Properti, Omaxe, and Unitech all have negative six-month returns.

Should I buy, sell or hold Alembic Ltd?

Are Alembic Ltd latest results good or bad?

Alembic Ltd's latest Q4 FY26 results are concerning, with standalone net profit dropping 59.54% year-on-year and 57.23% quarter-on-quarter, indicating significant operational challenges. While consolidated net profit showed slight improvement, the overall financial metrics reflect declining profitability and efficiency, leading to a negative market reaction.

Alembic Ltd's latest results for Q4 FY26 indicate a challenging financial performance. The standalone net profit fell significantly by 59.54% year-on-year to ₹9.61 crores, and there was also a substantial decline of 57.23% compared to the previous quarter. This sharp drop reflects severe operational stress within the company.<BR><BR>On a consolidated basis, the net profit was ₹67.13 crores, which, while showing a slight decline of 1.93% year-on-year, did improve by 11.64% quarter-on-quarter. However, the overall picture remains concerning, as the standalone results are a critical indicator of the company's core operations.<BR><BR>The operating margin, excluding other income, dropped to 33.66%, marking the lowest level in eight quarters and a significant decrease from 45.35% in the same quarter last year. Additionally, net sales were nearly flat year-on-year, with a slight decline of 0.38%, but a more pronounced drop of 19.24% from the previous quarter.<BR><BR>Investors reacted negatively to these results, leading to a 2.96% decline in the stock price on the results day, and the stock has underperformed significantly over the past year, down 21.81%. Overall, the latest results suggest that Alembic Ltd is facing considerable operational challenges, and the financial metrics indicate a trend of declining profitability and efficiency.

Is Alembic technically bullish or bearish?

As of December 1, 2025, Alembic's technical trend is mildly bearish, with mixed signals from indicators like MACD, RSI, and Bollinger Bands suggesting a cautious outlook and short-term weakness.

As of 1 December 2025, the technical trend for Alembic has changed from bearish to mildly bearish. The current stance is mildly bearish overall, driven by mixed signals across various indicators. The MACD shows a mildly bullish trend on the weekly chart but is mildly bearish on the monthly chart. The RSI indicates a bullish signal on the monthly timeframe, while the weekly shows no signal. Bollinger Bands and KST are both mildly bearish on the weekly and monthly charts. Daily moving averages remain bearish, suggesting short-term weakness. Dow Theory indicates no trend in both weekly and monthly perspectives. Overall, the indicators reflect a cautious outlook with a slight bearish bias.

How has been the historical performance of Alembic?

Alembic has shown significant growth from March 2023 to March 2025, with net sales increasing from 127.24 Cr to 221.88 Cr, and profit after tax rising from 80.62 Cr to 144.57 Cr. The company also improved its operating profit margin to 42.23% and consolidated net profit to 310.68 Cr by March 2025.

Answer:<BR>The historical performance of Alembic shows significant growth in net sales and profitability over the years, particularly from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Alembic's net sales have increased from 127.24 Cr in March 2023 to 221.88 Cr in March 2025, reflecting a strong upward trend. Total operating income has similarly risen, reaching 221.88 Cr in March 2025, up from 127.24 Cr in March 2023. The company's operating profit (PBDIT) has also shown substantial growth, climbing from 104.60 Cr in March 2023 to 168.60 Cr in March 2025, with an operating profit margin of 42.23% in March 2025, compared to 31.7% in March 2023. Profit before tax increased from 86.80 Cr in March 2023 to 155.51 Cr in March 2025, and profit after tax rose from 80.62 Cr to 144.57 Cr in the same period. The consolidated net profit reached 310.68 Cr in March 2025, up from 190.65 Cr in March 2023. On the balance sheet, total assets grew from 2,204.58 Cr in March 2023 to 2,503.00 Cr in March 2025, while total liabilities increased from 2,204.58 Cr to 2,503.00 Cr. Cash flow from operating activities improved significantly, rising to 86.00 Cr in March 2025 from 38.00 Cr in March 2023. Overall, Alembic has demonstrated a robust financial performance with increasing revenues, profits, and asset growth over the observed period.

Who are the top shareholders of the Alembic?

The top shareholders of Alembic include Nirayu Limited with 63.06%, 49 Foreign Institutional Investors holding 1.66%, and individual investors owning 21.94%. There are no mutual funds or public shareholders among the top holders.

The top shareholders of Alembic primarily consist of its promoters, with Nirayu Limited holding the largest stake at 63.06%. Additionally, there are 49 Foreign Institutional Investors (FIIs) who collectively hold 1.66% of the company. Individual investors also have a significant presence, owning 21.94% of the shares. Notably, there are no mutual funds currently invested in Alembic, and there are no public shareholders listed among the top holders.

Is Alembic overvalued or undervalued?

As of January 29, 2021, Alembic is considered very expensive and overvalued, with a PE ratio of 9.24, an EV to EBITDA of 30.14, and a year-to-date stock decline of 14.93%, indicating that its valuation does not align with industry standards despite comparable PE ratios to peers.

As of 29 January 2021, Alembic's valuation grade has moved from risky to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of 9.24, an EV to EBITDA of 30.14, and a PEG ratio of 0.59, which suggest that while the earnings are relatively low compared to the price, the growth expectations are not sufficiently high to justify the current valuation.<BR><BR>When compared to peers in the realty sector, Alembic's PE ratio is on par with its competitors, but its EV to EBITDA ratio is notably high, indicating potential overvaluation. For instance, if we consider similar companies, they may have lower EV to EBITDA ratios, which could suggest that Alembic's pricing does not align with industry standards. Additionally, Alembic's recent stock performance shows a decline of 14.93% year-to-date, contrasting with a 5.60% rise in the Sensex, further reinforcing the notion that the stock may be overvalued in the current market environment.

When is the next results date for Alembic?

No Upcoming Board Meetings

What is the bonus history of the Alembic?

Alembic Ltd had a bonus issue of 1:1 announced on September 27, 2013, with a record date of September 30, 2013, allowing shareholders to double their holdings by receiving an additional share for each share held.

Alembic Ltd has a bonus history that includes a 1:1 bonus issue announced with an ex-date of September 27, 2013. The record date for this bonus was September 30, 2013. This means that for every share held, shareholders received an additional share, effectively doubling their holdings at that time.

Has Alembic declared dividend?

Yes, Alembic Ltd has declared a dividend of 120%, amounting to ₹2.4 per share, with an ex-date of August 5, 2024. The company has shown strong long-term performance, particularly with a total return of 116.15% over the past five years.

Alembic Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 120%<BR>- Amount per share: 2.4<BR>- Ex-date: 05 Aug 24<BR><BR>Dividend Yield: 2.25%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -18.81%, with a dividend return of 0%, resulting in a total return of -18.81%.<BR><BR>For the 1-year period, the price return was 14.5%, the dividend return was 2.33%, leading to a total return of 16.83%.<BR><BR>Over the 2-year period, the price return was 63.92%, with a dividend return of 6.28%, culminating in a total return of 70.2%.<BR><BR>In the 3-year period, the price return was 63.4%, the dividend return was 10.83%, which resulted in a total return of 74.23%.<BR><BR>For the 4-year period, the price return was -10.93%, with a dividend return of 5.17%, leading to a total return of -5.76%.<BR><BR>In the 5-year period, the price return was 107.05%, the dividend return was 9.10%, resulting in a total return of 116.15%.<BR><BR>Overall, Alembic Ltd has declared a significant dividend of 120%, and while the total returns vary across different periods, the company has shown strong performance over the longer term, particularly in the 5-year period.